Translate AMICOR contents if you like

Thursday, January 05, 2017

12/15 Lipoxygenase

Mouse Model Points to Potential New Alzheimer’s Treatment

Source: Elsevier.
Treatment with an inhibitor of 12/15-lipoxygenase, an enzyme elevated in patients with Alzheimer’s disease (AD), reverses cognitive decline and neuropathology in an AD mouse model, reports a new study in Biological Psychiatry. The effects were observed after the AD-like phenotype was already established in the mice, which is promising for its potential therapeutic use, as neuropathology tends to develop many years before the appearance of AD symptoms in patients./.../

No comments: